Advertisement

Very high risk of intracranial hemorrhage and severe outcomes in adult patients with mild hemophilia: Sub-analysis of the EMO.REC Registry

Published:November 23, 2022DOI:https://doi.org/10.1016/j.thromres.2022.11.015
      Patients with mild hemophilia are usually considered low risk for spontaneous bleeding, such that they are rarely prescribed prophylaxis with clotting factor concentrates. Their natural history is undoubtedly more favorable than that of patients with moderate or severe hemophilia and they have a life expectancy very close to that of the general population [
      • Franchini M.
      • Favaloro E.J.
      • Lippi G.
      Mild hemophilia a.
      ]. However, advancing age also leads to an increase in typical diseases of adulthood and the elderly which increase bleeding risks, such as hypertension, cancer, and cardiac or cerebrovascular diseases, in patients with mild hemophilia, necessitating careful patient monitoring and initiation or modification of antihaemorrhagic therapy to reduce bleeding outcomes [
      • Franchini M.
      • Favaloro E.J.
      • Lippi G.
      Hemophilia, cancer and cardiovascular disease.
      ].

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Thrombosis Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Franchini M.
        • Favaloro E.J.
        • Lippi G.
        Mild hemophilia a.
        J. Thromb. Haemost. 2010; 8: 421-432
        • Franchini M.
        • Favaloro E.J.
        • Lippi G.
        Hemophilia, cancer and cardiovascular disease.
        Blood Coagul. Fibrinolysis. 2010; 21: 1-2
        • Benson G.
        • Auerswald G.
        • Dolan G.
        • et al.
        Diagnosis and care of patients with mild haemophilia: practical recommendations for clinical management.
        Blood Transfus. 2018; 16: 535-544
        • Srivastava A.
        • Santagostino E.
        • Dougall A.
        • et al.
        WFH guidelines for the management of hemophilia.
        Haemophilia. 2020; 26: 1-158
        • De la Corte-Rodriguez H.
        • Rodriguez-Merchan E.C.
        • Alvarez-Roman M.T.
        • et al.
        Arthropathy in people with mild haemophilia: exploring risk factors.
        Thromb. Res. 2022; 211: 19-26
        • Touré S.A.
        • Seck M.
        • Sy D.
        • Bousso E.S.
        • et al.
        Life-threatening bleeding in patients with hemophilia (PWH): a 10-year cohort study in Dakar, Senegal.
        Hematology. 2022 Mar 20; 27: 379-383
        • Zanon E.
        • Iorio A.
        • Rocino A.
        • et al.
        Intracranial haemorrhage in the italian population of haemophilia patients with and without inhibitors.
        Haemophilia. 2012; 18: 39-45
        • Connelly P.J.
        • Currie G.
        • Delles C.
        Sex differences in the prevalence, outcomes and management of hypertension.
        Curr. Hypertens. Rep. 2022; (Online haead of print)
        • Shi H.
        • Zhang S.
        Accurate prediction of anti-hypertensive peptides based on convolutional neural network and gated recurrent unit.
        Interdiscip. Sci. 2022; (Online haead of print)
        • Walsh C.
        • Boggio L.
        • Brown-Jones L.
        • et al.
        Identified unmet needs and proposed solutions in mild-to-moderate haemophilia: a summary of opinions from a roundtable of haemophilia experts.
        Haemophilia. 2021; 27: 25-32